Key Details
- Original intimation date: November 4th, 2026
- Scheduled meeting date: November 14, 2026
- Postponement announced: November 13, 2026
Reason for Postponement
The postponement is necessitated due to the continued illness of the Chief Financial Officer (CFO) of the Company. Consequently, the financial results and related supporting documents could not be finalized, rendering the Management unable to present them before the Audit Committee and the Board of Directors for consideration and approval.
Trading Window Status
In compliance with the Company's Code of Conduct for Prohibition of Insider Trading (BRNL Insider Code) framed pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015:
- Trading window for dealing in securities of the Company remains closed
- Closure period: Until 48 hours after declaration of Financial Results (Standalone & Consolidated) for Quarter and Half Year ended 30th September, 2026